middle.news
How Will Botanix’s A$45 Million Raise Transform Sofdra’s Growth and Supply Chain?
9:52am on Tuesday 17th of February, 2026 AEDT
•
Healthcare
Read Story
How Will Botanix’s A$45 Million Raise Transform Sofdra’s Growth and Supply Chain?
9:52am on Tuesday 17th of February, 2026 AEDT
Key Points
A$40 million two-tranche placement strongly supported by institutional investors
Underwritten security purchase plan to raise ~A$5 million, subject to shareholder approval
Funds allocated to API purchases, alternate supplier setup, marketing, and working capital
Offer includes 1 – 1 unlisted options exercisable at A$0.06, expiring January 2027
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
BOTANIX PHARMACEUTICALS (ASX:BOT)
OPEN ARTICLE